iBio (IBIO) Return on Equity (2016 - 2025)
iBio (IBIO) has disclosed Return on Equity for 15 consecutive years, with 0.44% as the latest value for Q4 2025.
- Quarterly Return on Equity rose 41.0% to 0.44% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.44% through Dec 2025, up 41.0% year-over-year, with the annual reading at 1.02% for FY2025, 50.0% down from the prior year.
- Return on Equity for Q4 2025 was 0.44% at iBio, up from 0.57% in the prior quarter.
- The five-year high for Return on Equity was 0.25% in Q1 2021, with the low at 2.28% in Q1 2023.
- Average Return on Equity over 5 years is 0.82%, with a median of 0.53% recorded in 2025.
- The sharpest move saw Return on Equity skyrocketed 989bps in 2021, then plummeted -199bps in 2023.
- Over 5 years, Return on Equity stood at 0.27% in 2021, then tumbled by -398bps to 1.37% in 2022, then soared by 57bps to 0.58% in 2023, then tumbled by -46bps to 0.85% in 2024, then soared by 48bps to 0.44% in 2025.
- According to Business Quant data, Return on Equity over the past three periods came in at 0.44%, 0.57%, and 1.4% for Q4 2025, Q3 2025, and Q2 2025 respectively.